Evaluation of the oral human abuse potential of Oxycodone DETERx® formulation (Xtampza® ER).
Saved in:
| Title: | Evaluation of the oral human abuse potential of Oxycodone DETERx® formulation (Xtampza® ER). |
|---|---|
| Authors: | Meske D; Manager, Clinical Development & Scientific Affairs, Collegium Pharmaceutical, Inc., Canton, Massachusetts., Kopecky EA; Vice President, Clinical Development; Head, Neuroscience, Collegium Pharmaceutical, Inc., Canton, Massachusetts., Passik S; Vice President, Scientific Affairs, Collegium Pharmaceutical, Inc., Canton, Massachusetts., Shram MJ; Director, Altreos Research Partners, Inc., Toronto, Ontario, Canada. |
| Source: | Journal of opioid management [J Opioid Manag] 2018 Sep/Oct; Vol. 14 (5), pp. 359-372. |
| Publication Type: | Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Weston Medical Pub Country of Publication: United States NLM ID: 101234523 Publication Model: Print Cited Medium: Print ISSN: 1551-7489 (Print) Linking ISSN: 15517489 NLM ISO Abbreviation: J Opioid Manag Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30387859 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evaluation of the oral human abuse potential of Oxycodone DETERx® formulation (Xtampza® ER). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Meske+D%22">Meske D</searchLink>; Manager, Clinical Development & Scientific Affairs, Collegium Pharmaceutical, Inc., Canton, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kopecky+EA%22">Kopecky EA</searchLink>; Vice President, Clinical Development; Head, Neuroscience, Collegium Pharmaceutical, Inc., Canton, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Passik+S%22">Passik S</searchLink>; Vice President, Scientific Affairs, Collegium Pharmaceutical, Inc., Canton, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Shram+MJ%22">Shram MJ</searchLink>; Director, Altreos Research Partners, Inc., Toronto, Ontario, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101234523%22">Journal of opioid management</searchLink> [J Opioid Manag] 2018 Sep/Oct; Vol. 14 (5), pp. 359-372. – Name: TypePub Label: Publication Type Group: TypPub Data: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Weston+Medical+Pub%22">Weston Medical Pub </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101234523 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1551-7489 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215517489%22">15517489 </searchLink><i>NLM ISO Abbreviation: </i>J Opioid Manag <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30387859 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.5055/jom.2018.0468 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 359 Titles: – TitleFull: Evaluation of the oral human abuse potential of Oxycodone DETERx® formulation (Xtampza® ER). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Meske D – PersonEntity: Name: NameFull: Kopecky EA – PersonEntity: Name: NameFull: Passik S – PersonEntity: Name: NameFull: Shram MJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2018 Sep/Oct Type: published Y: 2018 Identifiers: – Type: issn-print Value: 1551-7489 Numbering: – Type: volume Value: 14 – Type: issue Value: 5 Titles: – TitleFull: Journal of opioid management Type: main |
| ResultId | 1 |
